Introduction
In recent years, more effective therapies for cancer, especially systemic chemotherapy regimens, have been developed, and there has been striking improvement in the life expectancy of patients with advanced cancer. However, the benefit from systemic chemotherapy is limited in the case of brain metastases and, conversely, the recent prolongation of the life expectancy of many patients with advanced cancer has translated into a trend for an increase in brain metastases. It can thus be anticipated that there will be an even further increase in the importance of cancer therapy for brain metastases. The main treatment approaches for brain metastases are radiotherapy and surgical resection. Postoperative whole-brain irradiation is a standard therapeutic procedure for metastatic brain tumors. However, local recurrence rates of 10% to 30% have been reported even with concomitant whole-brain irradiation (Patchell et al. 1990; Schackert et al. 2001; Shinoura et al. 2002) . In addition, late complications of whole-brain irradiation can greatly affect quality of life in patients (DeAngelis et al. 1989 ). On the other hand, with regard to surgical resection, the development of surgical devices, such as neuro-navigation systems and intraoperative monitoring, has resulted in dramatic improvements in safety and reliability (Black and Johnson 2004) . However, with regard to improvement in the surgical technique itself, there has only been the recommendation for performance of en bloc resection including a surgical margin of about 5 mm (Modha et al. 2005) , and there have been hardly any innovations, even when compared with the case of malignant glioma surgery. Thus, at first glance, it would seem that metastatic brain tumor surgery has been established. However, in fact, the local recurrence rate is high in the case of surgical resection alone, and attempts are being made to improve the local recurrence rate by performing follow-up treatments such as whole-brain irradiation, stereotactic radiosurgery on the resection cavity, or local chemotherapy (Sills 2005; Kim et al. 2006; Mathieu et al. 2006; Ewend et al. 2007; Ranasinghe and Sheehan 2007) . The high local recurrence rate following surgical resection alone clearly implies the presence of residual tumor tissue (Patchell et al. 1998) . On the basis of this background, we have been trying various modifications of the surgical technique for surgical resection of metastatic brain tumors to improve the resection rate and the local recurrence rate. Our modifications are explained below. used in ophthalmology, and its safety has been established. The operative technique of using fluorescein sodium has a long history of use during brain tumor surgery, as reported by Moore and Murray (Moore et al. 1948; Murray 1982) . A special type of filter must be provided to observe the fluorescence, but Shinoda et al. reported that observation via a normal microscope under white light without using a special type of filter was also possible by intravenously injecting a double dose (20 mg/kg) in glioma surgery (Shinoda et al. 2003 ). We applied this technique to metastatic brain tumor surgery (Okuda et al. 2007 ). After induction of general anesthesia, and the dura is opened, fluorescein sodium (20 mg/kg) is injected intravenously. Tumor resection is performed >10 minutes after injection of fluorescein sodium. A yellow-stained tumor is visible under the white light of a normal microscope without a filter. The resected tumor using fluorescein sodium and the schematic diagram are shown in Figure 1 . The tumor parenchyma is stained, and the gliosis portion remains around the tumor. As shown in the diagram, the surrounding gliosis portion is aspirated and resected while carefully confirming the stained tumor. The edematous portion surrounding the tumor is also slightly stained, but it is easy to identify the boundary, and ideal en bloc resection can be achieved while confirming the stained tumor. Two cases are presented below. Case 1 was a patient with left frontal lobe metastasis from primary lung cancer ( Fig. 2A ). Prior to injection of fluorescein sodium (Fig. 3A) , the tumor could not be distinguished from the brain surface. After injection (Fig. 3B) , the yellow-stained tumor could be distinguished from www.intechopen.com the brain surface. Under magnification, the border was clearly discernable (Fig. 3C ). The border of the white-colored gliosis could also be discerned (Fig. 3D) , and en bloc resection was performed while performing suction and dissection (Fig. 3E ). The resection cavity is shown (Fig. 3F ). Postoperative MRI shows that complete resection was achieved (Fig. 2B ). Case 2 was a patient with left frontal lobe metastasis from primary renal cell carcinoma (Fig.  4A) . The tumor was located in the speech area. Fluorescein sodium was injected intravenously, the tumor was approached through minimal corticotomy, and the yellowstained tumor surface was confirmed (Fig. 5A, B) . En bloc resection was performed (Fig. 5C) . Postoperatively, the aphasia symptoms improved, and MRI confirmed that complete resection had been achieved (Fig. 4B) . Accordingly, even in cases of brain tumors located in eloquent areas, such as not only the speech area but also the motor area, use of fluorescein sodium makes it possible to carry out resection safely, without any special intraoperative monitoring. To date, we have used fluorescein sodium in more than 100 patients to facilitate surgical resection of metastatic brain tumors, and there have been absolutely no instances of permanent adverse reactions. Anaphylactic shock has been reported as a serious side effect, but it is rare (Tanahashi et al. 2006 ) and was not observed in our study. As transient adverse events, we have seen yellow staining of the skin, mucosa, and urine, but all cases resolved within 24 hours. This technique will contribute to increasing the resection rate in metastatic brain tumor surgery. Our data also showed statistically significant improvement in the local recurrence rate. Our fluorescence-guided surgery achieved successful local control rates of metastatic brain tumors in 80% of patients without whole-brain irradiation (Okuda et al. 2010) . Conversely, previous reports of conventional surgery have yielded successful local control rates of only 54% to 64% under similar conditions (Patchell et al. 1998; Schackert et al. 2001) . Although these results are only a guide, based on results from very few patients, fluorescence-guided surgery might enable avoidance or postponement of subsequent whole-brain irradiation, which will not only increase quality of life for patients, but also keeps whole-brain irradiation as a therapeutic option for subsequent brain metastases. This may help to prolong survival and decrease the rate of central nervous system death. This technique is simple, inexpensive, and does not require any special equipment. We are confident that it will be recognized as an important surgical innovation for application to the field of metastatic brain tumor surgery.
Surgical technique for a cystic-type metastatic brain tumor: transformation to a solid-type tumor using hydrofiber dressing
Cystic-type metastatic brain tumors may have injury to the wall during surgery, which can in some cases result in incomplete tumor resection and dissemination of cancer cells in cyst fluid (Nakagawa et al. 1992) . By transforming cystic-type tumors to solid-type tumors, we developed a surgical technique that makes it possible to carry out an ideal en bloc resection (Okuda et al. 2009 ). In this method, we insert a hydrofiber dressing (Aquacel; Convatec, London, UK) into a cyst, thereby transforming it to a solid-type tumor. Hydrofiber dressing is a coating agent with a high fluid-absorptive capacity that was originally used as a dressing for exudative wounds (Armstrong and Ruckley 1997). Hydrofiber dressing is a sodium carboxymethylcellulose hydrocolloid polymer with fluid-absorptive capacity equal to 25 times its own weight. This material also has a high capacity to retain absorbed water (Fig. 6) . 
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The hydrofiber dressing converts into a gel upon absorption of water, and it integrates with the tumor. As a result, the tumor becomes a soft, solid-type tumor. A flow diagram of the method for using the hydrofiber dressing during the surgical procedure is shown in Figure  7 . This method converted the cystic-type tumor into a solid-type, small-size tumor, and ideal en bloc resection could be performed. In addition, the hydrofiber dressing absorbs the fluid contents remaining inside the cyst, and by retaining that fluid, it helps prevent tumor cell dissemination during the operation. A case is presented below. The patient had a right occipital lobe metastasis of a squamous cell carcinoma (Fig. 8A) . First, the cyst was opened for aspiration of fluid (Fig. 9A, B) . A small cut was made on the tumor surface to aspirate the fluid contents of the cyst (Fig. 9C) , and then hydrofiber dressing was inserted into the cyst (Fig. 9D) . Physiologic saline was then injected to fill the cyst (Fig. 9E) . En bloc resection was performed (Fig. 9F) , and postoperative MRI revealed no residual tumor (Fig. 8B) . The tumor that was actually removed by en bloc resection is shown in Figure 10. www.intechopen.com Hydrofiber dressing is available in a blister pack that has been sterilized by irradiation. Numerous clinical trials for human wounds have confirmed the safety of hydrofiber dressing, and Hoekstra et al. observed few histologic reactions in rats in an examination of the biologic effects of hydrofiber dressing (Hoekstra et al. 2002) . There were no adverse events in the 12 patients in our study, and the safety of the method we used is likely to be high, because hydrofiber dressing is used in the cyst without direct contact with brain tissue. Application of this technique to cases of cystic-type metastatic brain tumors makes it possible to perform ideal en bloc resection of the tumor. In addition, it is easy to perform and inexpensive, and we believe that it will prove similarly useful in surgical resection of other cystic brain tumors.
Conclusion
We have described two surgical innovations for metastatic brain tumors. Brain metastases cause serious problems in terms of the quality of life and prognosis of cancer patients. Surgery for metastatic brain tumors can have both good and bad sequelae. The surgical techniques we have described are both easy and safe, and they increase the resection rate while improving the local recurrence rate. As a result, we think that these methods will have great benefit to patients by helping avoid and/or delay radiotherapy, while also improving the clinical symptoms. The focus of the book Diagnostic Techniques and Surgical Management of Brain Tumors is on describing the established and newly-arising techniques to diagnose central nervous system tumors, with a special focus on neuroimaging, followed by a discussion on the neurosurgical guidelines and techniques to manage and treat this disease. Each chapter in the Diagnostic Techniques and Surgical Management of Brain Tumors is authored by international experts with extensive experience in the areas covered.
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